Literature DB >> 7678584

Opposing effects of tumor necrosis factor alpha and leukemia inhibitory factor in lipopolysaccharide-stimulated myelopoiesis.

R Kreisberg1, M S Detrick, R N Moore.   

Abstract

Three myelopoietically active, lipopolysaccharide (LPS)-stimulated monokines, interleukin-1 alpha (IL-1 alpha), tumor necrosis factor alpha (TNF-alpha), and leukemia inhibitory factor (LIF), were tested for effect in an in vitro model for LPS-induced inflammatory murine monocytopoiesis. Neither cytokine stimulated clonal proliferation of marrow-derived progenitors; however, both IL-1 alpha and TNF-alpha enhanced macrophage colony-stimulating factor (M-CSF)-dependent colony formation. The additional progenitors stimulated by IL-1 alpha and TNF-alpha to form colonies in response to M-CSF were equivalent to the precommitment, transitional progenitors stimulated by M-CSF and bacterial LPS. In addition, the additional colonies elicited by IL-1 alpha and TNF-alpha were not additive in cultures containing both M-CSF and LPS, indicating these colonies arose from the same LPS-responsive, two-signal-dependent transitional progenitors. Leukemia inhibitory factor did not influence M-CSF-stimulated colony formation; however, LIF effected a dose-dependent inhibition of colony formation by transitional progenitors responding to combinations of M-CSF and LPS, IL-1 alpha, TNF-alpha, or an additional transitional cell costimulant, substance P. Neutralizing anti-murine TNF-alpha antibodies abrogated transitional cell colony formation stimulated by combinations of M-CSF and TNF-alpha, IL-1 alpha, LPS, or substance P but had no effect on colony formation stimulated solely by M-CSF. The results indicate that TNF-alpha may be an important positive stimulus for commitment of progenitors to the mononuclear phagocyte lineage and that TNF-alpha may be the endogenous regulator of the costimulatory effects of LPS, IL-1, and substance P. In addition, the results indicate that LIF may play an opposing negative regulatory role acting to inhibit LPS and TNF-alpha stimulation of the transitional progenitors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678584      PMCID: PMC302745          DOI: 10.1128/iai.61.2.418-422.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Tumor necrosis factor: receptors on hematopoietic cells.

Authors:  R Munker; J DiPersio; H P Koeffler
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

Review 2.  Clinical role of colony stimulating factors.

Authors:  W Brugger; F M Rosenthal; L Kanz; R Mertelsmann
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

Review 3.  Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.

Authors:  C A Dinarello
Journal:  Curr Opin Immunol       Date:  1991-12       Impact factor: 7.486

4.  Neurotensin regulation of macrophage colony-stimulating factor-stimulated in vitro myelopoiesis.

Authors:  R N Moore; A P Osmand; J A Dunn; J G Joshi; J W Koontz; B T Rouse
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

5.  Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia.

Authors:  M Mori; K Yamaguchi; K Abe
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

6.  Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor.

Authors:  H Baumann; G G Wong
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

Review 7.  LIF: lots of interesting functions.

Authors:  D J Hilton
Journal:  Trends Biochem Sci       Date:  1992-02       Impact factor: 13.807

8.  Control of HILDA/LIF gene expression in activated human monocytes.

Authors:  D Grolleau; J P Soulillou; I Anegon
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

9.  Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.

Authors:  H E Broxmeyer; B Sherry; S Cooper; F W Ruscetti; D E Williams; P Arosio; B S Kwon; A Cerami
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

10.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.

Authors:  R L Williams; D J Hilton; S Pease; T A Willson; C L Stewart; D P Gearing; E F Wagner; D Metcalf; N A Nicola; N M Gough
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

View more
  1 in total

1.  Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.

Authors:  R Kreisberg; H E Broxmeyer; R N Moore
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.